Bc Platforms Acquires Medexprim, Paving The Way For Global Leadership In Real-World Data And Real-World Evidence Analytics
Acquiring Company
BC Platforms
Acquired Company
Medexprim
Description
BC Platforms, a global leader in healthcare data management and analytics, today announced it has acquired Medexprim, a leading European Real-World Data company. The acquisition significantly expands BC Platforms' ability to provide global biopharma partners with secure access to Real-World clinical and imaging Data assets across Europe.
Quick answer
BC Platforms is acquiring Medexprim, announced December 7, 2023. BC Platforms is based in Zurich, Zurich, Switzerland.
- How much did BC Platforms pay for Medexprim?
- The deal value was not disclosed.
- What does BC Platforms do?
- BC Platforms is a global leader in building data networks for the life sciences industry and provides versatile technology platforms for personalised medicine, accelerating the translation of innovations into clinical..
- Where are BC Platforms and Medexprim based?
- BC Platforms is based in Zurich, Zurich, Switzerland. Medexprim is based in Toulouse, Occitania, France.
- Who are the decision-makers at BC Platforms?
- Fundz holds 2 contacts at BC Platforms. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Analytics and Research Services
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Qlik Acquires Kyndi to Advance AI-Driven Business Outcomes (January 18, 2024)
- Optimizerx Announces Completion Of Medicx Acquisition And Sets Third Quarter 2023 Conference Call For November 6, 2023, At 8:30 A.M. Et (October 25, 2023)
- Edb Acquires Splitgraph For Data Lake And Data Warehousing Capabilities (October 24, 2023)
- Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics (January 18, 2024)
- Avenu Insights & Analytics, an Arlington Capital Partners Portfolio Company, Acquires Finvi’s State and Local Government Division (January 17, 2024)
- Synopsys to Acquire Ansys, Creating a Leader in Silicon to Systems Design Solutions (January 16, 2024)
Who to call at BC Platforms, and when
When BC Platforms changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day BC Platforms raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BC Platforms, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BC Platforms. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BC Platforms makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Medexprim?
Medexprim was acquired by BC Platforms, based in Zurich. The deal was reported on December 7, 2023. BC Platforms is privately held and operates in Information Technology.
When did BC Platforms acquire Medexprim?
BC Platforms's acquisition of Medexprim was reported on December 7, 2023. BC Platforms, a global leader in healthcare data management and analytics, today announced it has acquired Medexprim, a leading European Real-World Data company. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Medexprim do?
Medexprim is the European leader in secure imaging and clinical data extraction to accelerate medical research. As a Real-World data specialist, Medexprim builds bridges between European academic hospitals, and pharmaceutical, AI and medical device companies. It is privately held, operating in Research Services, and is based in Toulouse.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.